In therapeutic studies, the iPSC-based vaccine inhibited CRC tumor growth by increasing CD8+ T cell infiltration and activating cleaved caspase-3, ultimately inducing tumor apoptosis. This evidence concerns the gene CD8A and colorectal carcinoma.